Clinical trials in palliative care: A systematic review of their methodological characteristics and of the quality of their reporting

BMC Palliative Care

Volumn 16, Issue 1, 2017, Pages

  Bouça Machado, Raquel ^a   Rosário, Madalena ^a   Alarcão, Joana ^a   Correia Guedes, Leonor ^a   Abreu, Daisy ^a   Ferreira, Joaquim J ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Clinical trials; Methodological quality; Palliative care; Risk of bias

Indexed keywords

ARTICLE; AUSTRALIA; CANADA; CANCER THERAPY; CITATION ANALYSIS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DYSPNEA; HOME CARE; HUMAN; INFORMATION PROCESSING; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; MENTAL HEALTH; METHODOLOGY; NAUSEA; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PLACEBO EFFECT; PUBLICATION; QUALITY OF LIFE; SYMPTOM; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; MEASUREMENT ACCURACY; MEDICINE; PROCEDURES; QUESTIONNAIRE; SAMPLE SIZE; STANDARDS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DATA ACCURACY; HUMANS; MEDICINE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; RESEARCH DESIGN; SAMPLE SIZE; SURVEYS AND QUESTIONNAIRES;

EID: 85010773903     PISSN: None     EISSN: 1472684X     Source Type: Journal    
DOI: 10.1186/s12904-016-0181-9     Document Type: Article

References (54)

1. Sigurdardottir KR, Oldervoll L, Hjermstad MJ, Kaasa S, Knudsen AK, Løhre ET, et al. How are palliative care cancer populations characterized in randomized controlled trials? A literature review. J Pain Symptom Manag. 2014;47:906-14. e17.
2. Pastrana T, Jünger S, Ostgathe C, Elsner F, Radbruch L. A matter of definition - key elements identified in a discourse analysis of definitions of palliative care. Palliat Med. 2008;22:222-32.
3. Sepúlveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: the world health organization's global perspective. J Pain Symptom Manage. 2002;24:91-6.
4. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J. 1996;312:71-2.
5. Visser C, Hadley G, Wee B. Reality of evidence-based practice in palliative care. Cancer Biol. Med. 2015;12:193-200.
6. McIlfatrick SJ, Murphy T. Palliative care research on the island of Ireland over the last decade: a systematic review and thematic analysis of peer reviewed publications. BMC Palliat Care. 2013;12:33.
7. Flemming K, Adamson J, Atkin K. Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials. Palliat Med. 2008;22:123-31.
8. Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, et al. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med. 2010;13:1407-13. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA.
9. Aoun SM, Nekolaichuk C. Improving the Evidence Base in Palliative Care to Inform Practice and Policy: Thinking Outside the Box. J Pain Symptom Manag. Elsevier; 2014;48:1222-35.
10. Kelley AS, Morrison RS. Palliative care for the seriously Ill. N Engl J Med. 2015;373:747-55.
11. Bakitas MA, Lyons KD, Dixon J, Ahles TA. Palliative care program effectiveness research: developing rigor in sampling design, conduct, and reporting. J Pain Symptom Manag. 2006;31:270-84. Elsevier.
12. Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: a systematic review. JAMA. 2008;299:1698-709.
13. Hui D, Glitza I, Chisholm G, Yennu S, Bruera E. Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer. 2013;119:1098-105.
14. Currow DC, Wheeler JL, Glare PA, Kaasa S, Abernethy AP. A framework for generalizability in palliative care the problem: why is generalizability different from other clinical. J Pain Symptom Manag. 2009;37:373-86. Elsevier Inc.
15. Armijo-Olivo S, Fuentes CJ, Rogers T, Hartling L, Saltaji H, Cummings G. How should we evaluate the risk of bias of physical therapy trials?: a psychometric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: a study protocol. Syst Rev. 2013;2:88.
16. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28-55.
17. Consort - Welcome to the CONSORT Website. http://www.consort-statement.org/. Accessed 21 Dec 2016.
18. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
19. Campion EW, Kelley AS, Morrison RS. Palliative care for the seriously Ill. N Engl J Med. 2015;373:747-55.
20. Twycross R. Patient care: past, present, and future. Omega (Westport). 2007;56:7-19.
21. Mazzocato C, Sweeney C, Bruera E. Clinical research in palliative care: patient populations, symptoms, interventions and endpoints. Palliat Med. 2001;15:163-8.
22. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library. Wiley: Chichester; 2006;(4).
23. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: A comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: Methodological research. J. Eval. Clin. Pract. 2012;18:12-8.
24. Han CJ, Yang GS. Fatigue in irritable bowel syndrome: a systematic review and meta-analysis of pooled frequency and severity of fatigue. Asian Nurs Res (Korean Soc Nurs Sci). 2016;10:1-10. Elsevier.
25. Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ. 2013;346:e8668. BMJ Group.
26. Albers G, Harding R, Pasman HRW, Onwuteaka-Philipsen BD, Hall S, Toscani F, et al. What is the methodological rigour of palliative care research in long-term care facilities in Europe? A systematic review. Palliat Med. 2012;26:722-33.
27. Kaasa S, Hjermstad MJ, Loge JH. Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliat Med. 2006;20:727-34.
28. Lorenz KA, Lynn J, Morton SC, Ph D, Dy SM, Shugarman LM, et al. Methodological approaches for a systematic review of end-of-life care. J Palliat Med. 2005;8:4-11.
29. Bausewein C, Higginson IJ. Challenges in defining "palliative care" for the purposes of clinical trials. Curr Opin Support Palliat Care. 2012;6:471-82.
30. Dening T, Dening KH. Palliative care in dementia: does it work? Maturitas Elsevier Ireland Ltd. 2015;83:1-2.
31. Mitchell G. Decision-making in dementia care. Int J Palliat Nurs. 2013;21:536-41.
32. Hui D, Parsons HA, Damani S, Fulton S, Liu J, Evans A, et al. Quantity, design, and scope of the palliative oncology literature. Oncologist. 2011;16:694-703.
33. Sleeman KE, Murtagh FE. Increasing the value of research in palliative care. Palliat Med. 2014;28:1165-6.
34. Johnston G, Abraham C. The WHO objectives for palliative care: to what extent are we achieving them? Palliat Med. 1995;9:123-37.
35. Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D, Hellmich M, et al. Recommending early integration of palliative care - does it work? Support Care Cancer. 2012;20:507-13.
36. Abernethy AP, Currow DC, Wurzelmann J, Janning SW, Bull J, Norris JF, et al. Enhancing enrollment in palliative care trials: key insights from a randomized, Placebo-controlled study. J Support Oncol. 2010;8:139-44.
37. Hussain JA, White IR, Langan D, Johnson MJ, Currow DC, Torgerson DJ, et al. Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses. J Clin Epidemiol. 2016;74:57-65. Elsevier Inc.
38. Latronico N, Botteri M, Minelli C, Zanotti C, Bertolini G, Candiani A. Quality of reporting of randomised controlled trials in the intensive care literature. A systematic analysis of papers published in intensive care medicine over 26 years. Intensive Care Med. 2002;28:1316-23.
39. Agar M, Luckett T. Outcome measures for palliative care research. Curr Opin Support Palliat Care. 2012;6:500-7.
40. Jassem J, Ramlau R, Santoro A, Schuette W, Chemaissani A, Hong S, et al. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol. 2008;26:1698-704.
41. Nipp RD, Currow DC, Cherny NI, Strasser F, Abernethy AP, Zafar SY. Best supportive care in clinical trials: review of the inconsistency in control arm design. Br J Cancer. 2015;113:6-11. Nature Publishing Group.
42. Zafar SY, Currow D, Abernethy AP. Defining best supportive care. J Clin Oncol. 2008;5139.
43. Mayer D. Essential Evidence-Based Medicine - 2nd edition. Kingdom; Cambridge University Press; 2010.
44. Hardy J. Placebo-controlled trials in palliative care: the argument for. Palliat Med. 1997;11:415-8.
45. Kirkham SR, Abel J. Placebo-controlled trials in palliative care: the argument against. Palliat Med. 1997;11:489-92.
46. Chen EK, Riffin C, Reid MC, Adelman R, Warmington M, Mehta SS, et al. Why is high-quality research on palliative care so hard to do? Barriers to improved research from a survey of palliative care researchers. J. Palliat. Med. 2014;17:782-7.
47. Lai R. Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol. 2006;24:1136-44.
48. Latronico N, Metelli M, Turin M, Piva S, Rasulo FA, Minelli C. Quality of reporting of randomized controlled trials published in intensive care medicine from 2001 to 2010. Intensive Care Med. 2013;39:1386-95.
49. Juni P, Altman DG, Egger M. Assessing the Quality of Randomised Controlled Trials. Syst. Rev. Heal. Care. London: BMJ Publishing Group; p. 87-108.
50. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609-13.
51. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12.
52. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I: medical. Stat Med. 1989;8:441-54.
53. Vale CL, Tierney JF, Burdett S. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews. BMJ. 2013;346:f1798-f1798.
54. Piggott M, McGee H, Feuer D. Has CONSORT improved the reporting of randomized controlled trials in the palliative care literature? A systematic review. Palliat Med. 2004;18:32-8.